Plasmodium falciparum-infected humanized mice: a viable preclinical tool

Rajeev K Tyagi1

  • 1Division of Cell Biology & Immunology, Biomedical Parasitology & Nano-immunology Lab, CSIR-Institute of Microbial Technology (IMTECH), Sec-39A, Chandigarh, 160036, India.

Immunotherapy
|August 23, 2021
PubMed

Insights

Mouse-human chimeras offer insights into infectious diseases like malaria. Humanized immunodeficient mice are crucial for studying Plasmodium falciparum due to limitations in in vitro models and drug resistance challenges.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Parasitology
  • Chimeric Mice Models

Background:

  • In vitro culture of Plasmodium falciparum is insufficient for understanding its complex biology, drug resistance, and pathogenesis.
  • Challenges in malaria research include the parasite's complex life cycle, genome, drug resistance evolution, and diagnostic limitations.
  • The lack of effective vaccines and increasing drug resistance necessitate advanced research models.

Purpose of the Study:

  • To highlight the utility of humanized immunodeficient mouse models for studying Plasmodium falciparum.
  • To explore the application of chimeric mice in understanding infectious diseases, particularly malaria.
  • To discuss the role of human cell/tissue reconstituted mice in overcoming limitations of in vitro studies.

Main Methods:

  • Utilizing various immunodeficient mouse strains (e.g., TK/NOG, FRG/NOD, NOD/SCID/IL-2 receptor γ chain, NSG, NRG) for humanization.
  • Employing CD34+ human hematopoietic stem cell-engrafted NSG mice to reconstitute the human immune system.
  • Challenging these humanized mice with Plasmodium falciparum to study infection dynamics.

Main Results:

  • Humanized immunodeficient mice support the engraftment and study of Plasmodium falciparum infection.
  • These models facilitate research into parasitology, pharmacology, and immunology related to malaria.
  • Human immune system (CD34+ HSC-NSG) mice enable the study of immune effectors in systemic inflammatory diseases.

Conclusions:

  • Humanized immunodeficient mice are essential tools for advancing malaria research and understanding Plasmodium falciparum.
  • These models provide a more comprehensive platform than in vitro cultures for drug discovery and vaccine development.
  • Chimeric mouse models are critical for dissecting host-pathogen interactions and developing strategies against infectious diseases.